As guaranteed critical illness rates become more expensive and sales start to slow down, Johanna Gornitzki asks if this golden product has finally reached the end of the road Click here to download pdf
For many years, individual critical illness (CI) was seen as the number one product in the protection market. Sales were high, premiums affordable and the market continued to see year on year growth. However, changes in the sector, particularly in the last 12 months, have prompted a shift in opinion as sales of individual CI fell by 18.5% for the first time in over ten years, according to the Association of British Insurers. The outlook for this year is not looking much brighter, with industry experts predicting that sales for 2004 will either remain stagnant or continue to drop even furth...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes